FDA
approval
· 2021-03-17
FDA Approved: CHILDRENS ALLEGRA ALLERGY — Supplemental Application (Chattem, Inc.)
Summary
The FDA approved a supplemental application for Children's Allegra Allergy to update its labeling for fexofenadine HCl, marketed by Chattem, Inc.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for CHILDRENS ALLEGRA ALLERGY (FEXOFENADINE HYDROCHLORIDE)